Patent · US Active

Monocyclic heterocycles as kinase inhibitors

US7714138B2 · kind B2 · utility

4Cited by
34References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 17, 2008
Grant dateMay 11, 2010
Priority date—
Expiry dateOct 17, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to compounds having the formulaand methods for using them for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.